-
New omicron strain now makes up 40% of US cases: 3 notes
In one week, the prevalence of XBB.1.5 — an offshoot of omicron subvariant XBB — more than doubled in the U.S., according to the latest CDC estimates. -
CDC's FluView report: 7 things to know
As flu activity continues its descent from an unusually early and strong season, the past week saw a flu hospitalization rate four times higher than the same week each year since 2010, according to the CDC's FluView report. -
Youth diabetes cases to more than double in coming decades, CDC warns
A "startling" surge in diabetes diagnoses among American youth is predicted by 2060, according to a Dec. 29 CDC report. -
Less than a quarter of NICUs conduct social determinants of health screenings
Less than 25 percent of neonatal intensive care units across the U.S. screen for universal social determinants of health, according to a study published Nov. 1 in Hospital Pediatrics. -
COVID-19 admissions flatten: What CDC predicts for January
COVID-19 hospitalizations appear to be leveling off in the U.S. after a steady month of growth, though it's still unclear how the holiday season may affect this trend. -
US to enact testing requirement for travelers from China: 3 COVID-19 updates
Beginning Jan. 5, travelers from China, Hong Kong and Macau will be required to test negative for COVID-19 before boarding flights headed to the U.S., the CDC said in a Dec. 28 announcement. The move comes as concern mounts over a growing surge of cases in China. -
Experts worry China's COVID-19 wave could spur new variant
The COVID-19 crisis in China is creating more opportunities for the virus to change, spurring concern that a new variant could emerge, CBS News reported Dec. 25. -
Vaccine hesitancy fueling resurgence of diseases, experts say
A measles outbreak in Columbus, Ohio, is sparking concern among health officials who believe that increased vaccine hesitancy will intensify a resurgence of vaccine-preventable diseases, according to The Washington Post. -
Flu activity remains high as descent begins: 5 notes
The nation's worst flu outbreak in more than a decade is slowing down, though flu activity remains high overall, according to the CDC's latest FluView report. -
New omicron subvariant on path to dominance, data suggests
Omicron subvariant XBB is encroaching on BQ.1 and BQ.1.1's dominance, CDC data shows, as it accounts for 18.3 percent of U.S. cases and makes up more than 1 in 2 infections in the Northeast. -
CDC alerts clinicians on severe strep A increase
The CDC issued a health advisory Dec. 22 to alert the medical community of a rise in severe strep A infections among children. -
NIH, Sheba Medical Center create pandemic research institute
The National Institutes of Health is partnering with Sheba Medical Center in Israel to create a pandemic research institute, the organizations said Dec. 22. -
BF.7: 5 notes on the subvariant fueling surge in China
Global health experts are closely monitoring COVID-19 activity in Beijing where the highly transmissible omicron subvariant BF.7 is fueling a surge in cases. -
RSV peaks as experts share better outlook for next winter
While the respiratory "tripledemic" continues to slam emergency rooms and children's hospitals, there are two glimmers of hope on the horizon, according to a Dec. 22 report in The New York Times. -
US life expectancy at 25-year low, CDC says
Last year, the average life expectancy for Americans shortened by over seven months, according to new CDC data. -
'Immunity debt' debate persists as holidays approach
This winter is unlike the first two pandemic winters, with all common respiratory viruses back in full gear. With many people coming down with the flu, respiratory syncytial virus and/or COVID-19, chatter about "immunity debt" has persisted for months. -
COVID-19 admissions up 14% in 2 weeks: 3 updates
COVID-19 cases and hospitalizations are steadily rising in the U.S. as new, highly transmissible omicron subvariants account for more than 75 percent of cases nationwide. -
3 subvariants expand their dominance to 76% of cases: 10 CDC notes
As researchers continue to test the efficacy of the bivalent boosters and COVID-19 treatments, about 3 in 4 COVID-19 infections are from omicron subvariants BQ.1.1, BQ.1 and XBB, CDC data shows. -
10 most common COVID-19 symptoms
Sore throat and runny nose are now the two most common symptoms reported among COVID-19 patients, according to new data from the U.K.'s ZOE Health Study. -
COVID-19 tests are free again amid case uptick
The U.S. resumed its program that ships four free COVID-19 tests to every household Dec. 15 as the mostly vaccinated but scarcely boosted nation braces for a winter surge in cases.
Page 40 of 50